Contamination Doctors Generic Drugs Protein 
XTalks
SEPTEMBER 14, 2020
The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. The University of Oxford/AstraZeneca partnership, in turn, is testing a viral-vectored coronavirus vaccine that again expresses the spike protein of SARS-CoV-2 virus. The mask costs all of about $40 to make.
The Pharma Data
MAY 4, 2021
down 21%, driven by a negative impact from the COVID-19 pandemic resulting in a decline in patient visits to doctors for preventative health purposes, as well as the loss of patent protection in the U.S. Hospital products, which grew 10% operationally to $2.3 down 7%, which reflects relatively stable U.S. Chantix in the U.S.,
Expert insights. Personalized for you.
92 
Let's personalize your content